Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience. Mohammad AJ, Smith RM, Chow YW, Chaudhry AN, Jayne DRW J Rheumatol. 2015 Aug 15. PMID: 26276966. Abstract CommentRecommendBookmarkWatch